Literature DB >> 9103223

Osteoclasts, macrophages, and the molecular mechanisms of bone resorption.

S L Teitelbaum1, M M Tondravi, F P Ross.   

Abstract

The osteoclast is a physiological polykaryon and the major if not exclusive resorptive cell of bone. It participates in bone remodeling, repair, and growth and mobilization of mineral to meet homeostatic demands. Most importantly, osteoporosis, a disease endemic in Western society and Asia, is always a reflection of enhanced osteoclastic activity relative to bone formation by osteoblasts. In fact, all forms of anti-osteoporosis therapy proven successful involve inhibition of osteoclastic bone resorption. Bone resorption is regulated either by altering recruitment of osteoclast precursors into fully differentiated resorptive polykaryons or modulating the rate at which mature osteoclasts degrade bone. With this in mind, our laboratory has focused on the molecular mechanisms of osteoclast differentiation and the means by which the cell degrades bone matrix.

Entities:  

Mesh:

Year:  1997        PMID: 9103223     DOI: 10.1002/jlb.61.4.381

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Immunomodulatory and therapeutic role of Cinnamomum verum extracts in collagen-induced arthritic BALB/c mice.

Authors:  Mirza Muhammad Fahd Qadir; Attya Bhatti; Muhammad Usman Ashraf; Mansur Abdullah Sandhu; Sidrah Anjum; Peter John
Journal:  Inflammopharmacology       Date:  2017-04-20       Impact factor: 4.473

4.  Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.

Authors:  Mizuho Kittaka; Kotoe Mayahara; Tomoyuki Mukai; Tetsuya Yoshimoto; Teruhito Yoshitaka; Jeffrey P Gorski; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

5.  Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse.

Authors:  Seung Wook Kim; Jang Seong Kim; John Papadopoulos; Hyun Jin Choi; Junqin He; Marva Maya; Robert R Langley; Dominic Fan; Isaiah J Fidler; Sun-Jin Kim
Journal:  Int Immunopharmacol       Date:  2011-01-18       Impact factor: 4.932

6.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.

Authors:  Oxana P Lazarenko; Sylwia O Rzonca; William R Hogue; Frances L Swain; Larry J Suva; Beata Lecka-Czernik
Journal:  Endocrinology       Date:  2007-03-01       Impact factor: 4.736

8.  Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: an in silico and in vitro study.

Authors:  Sera Kang; Muhammad Hanif Siddiqi; Sung Joo Yoon; Sungeun Ahn; Hae-Yong Noh; Natarajan Sathish Kumar; Yeon-Ju Kim; Deok-Chun Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-07-01       Impact factor: 2.416

9.  Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.

Authors:  Hao Zhang; Stephen B Doty; Christine Hughes; David Dempster; Nancy Pleshko Camacho
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

10.  Treatment for experimental autoimmune neuritis with clodronate (Bonefos).

Authors:  Aviva Katzav; Hofit Bina; Ramona Aronovich; Joab Chapman
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.